ELMIRON® is supplied in white opaque hard gelatin capsules containing 100 mg pentosan polysulfate sodium, microcrystalline cellulose, and
magnesium stearate. It is formulated for oral use.
ELMIRON can help reduce the pain and discomfort of IC. Scientific studies show that ELMIRON relieves bladder pain in 38% to 61% of IC patients after 3 months. Patients who continue treatment may experience relief by 6 months. Relief may be gradual, and some people don't see significant improvement for 3 to 6 months. ELMIRON does not heal the bladder wall. Instead, ELMIRON may protect the bladder wall while it heals, which is a slow process. Therefore, you need to continue with your treatment. The majority of patients who take ELMIRON begin to respond in the first 3 months. Others may need 3 to 6 months of therapy before obtaining relief.
Candrug.com supplies only genuine Elmiron from Canada and Australia shipped using Canadian and Australian packaging. The Elmiron from Canada is manufactured by Janssen Ortho LLC and is manufactured in Puerto Rico. The Elmiron from Australia is manufactured by Arthropharm Pty Limited. ELMIRON is a Registered Trademark of Teva Branded Pharmaceutical Products R&D, Inc. under license to Janssen Pharmaceuticals, Inc. This offer is neither endorsed nor authorized by Johnson & Johnson, Janssen Ortho LLC, Arthropharm Pty Limited or the Alza Corporation. Candrug.com has no affiliation whatsoever with Johnson & Johnson, Janssen Pharmaceuticals, Janssen Ortho, Arthropharm Pty Limited or the Alza Corporation.
Generic Pentosan Polysulfate Sodium is manufactured by Swati Spentose Pvt Ltd in India and has no affiliation whatsoever with Johnson & Johnson, Janssen Pharmaceuticals, Janssen Ortho, Arthropharm Pty Limited or the Alza Corporation.
ELMIRON has been shown to be well tolerated. The most common side effects were diarrhea, nausea, hair loss, headache, rash, upset stomach, abdominal pain, liver function abnormalities, and dizziness. Overall, each of these side effects occurred at rates of 1% to 4%. When side effects did occur, they were generally mild and usually did not interfere with continuing treatment. Hair loss, when it occurred, was almost always limited to a single area of the scalp, and grew back when ELMIRON was discontinued. ELMIRON is a weak anticoagulant (blood thinner) that may increase bleeding. Call your doctor if you will be undergoing surgery or will be taking anticoagulant therapy such as warfarin, heparin, high doses of aspirin, or anti-inflammatory drugs such as ibuprofen.